Tags Posts tagged with "Cancer"

Cancer

by -
0 137

Journey benefits cancer research, education and treatment

Kevin Rooney is ready to take on a 150-mile bike ride for cancer research. Photo from CRI
Kevin Rooney is ready to take on a 150-mile bike ride for cancer research. Photo from CRI

This weekend’s 150-mile journey through Westchester, from Yonkers to Pound Ridge, isn’t Kevin Rooney’s first lengthy bike ride, but this one is definitely personal.

Rooney, 53, has so far raised more than $3,200 for the Cancer Research Institute’s inaugural New York Ride to Conquer Cancer, in which he is participating in honor of his parents, George and Mary, and his father-in-law, Clifford, all of whom died from cancer. The Mount Sinai resident is also riding in honor of his wife Lynn’s aunt and a close family friend who have battled the disease, which affects more than 1 million people in the United States every year, according to the American Cancer Society.

“I’m thinking about them and doing what I can do to make things better for them,” Rooney said.

The nonprofit Cancer Research Institute will use the funds for research, treatment and education.

An avid cycler for more than 20 years, the ride is far from Rooney’s first. But the father of two kids — Kathryn, 11, and Colin, 10 — has a busy schedule that leaves not as much time to race as he once did. In order to prepare for the June 6 to June 7 expedition, Rooney said he has been riding about three times a week. He typically gets up at 4 a.m. and works out for about an hour on a training bicycle, and tries to go out on weekends for a 50- to 60-mile ride.

“I just wanted to do something to the best of my athletic ability,” Rooney said.

Kevin Rooney with his wife, Lynn, and their children, Colin and Kathryn. Photo from CRI
Kevin Rooney with his wife, Lynn, and their children, Colin and Kathryn. Photo from CRI

He said cycling enables him to work through stress and acts as a meditation ritual.

Lynn Rooney said her husband’s motivation and commitment to the cause is “very encouraging,” and “something that I admire.”

Kevin Rooney was at first a little concerned about asking people to donate money, but as the donations started pouring in, he realized just how many people the disease affects.

“It touches people,” he said. “You find out how prevalent [the disease is].”

While his family won’t watch from the race sidelines, as Colin — an athlete like his dad — has a soccer match Rooney didn’t want him to miss, the father will have some guidance along the way. He said the pictures of those who inspired him are printed on his race number and will be tagging along for the ride.

For more information visit, www.ridetovictory.org.

by -
0 1137
An exterior view of the Stony Brook University Cancer Center. Photo from SBU

By L. Reuven Pasternak, MD

Thanks to major advances in cancer prevention, early detection and treatment, many patients are enjoying longer lives and maintaining their quality of life, as the number of cancer survivors grows.

Anyone living with a history of cancer — from the moment of diagnosis through the remainder of life — is a cancer survivor, according to the National Cancer Survivors Day Foundation. In the United States alone, there are more than 14 million cancer survivors. That’s cause for celebration, and for the past 10 years, that’s exactly what we’ve been doing at Stony Brook University Cancer Center at our annual National Cancer Survivors Day event.

Stony Brook’s 11th annual celebration will take place on Sunday, June 14, from 11 a.m. to 3 p.m., at the Cancer Center, and will feature a talk about the Cancer Survivorship Movement by inspirational speaker Doug Ulman. A three-time cancer survivor and a globally recognized cancer advocate, Ulman, with his family, founded the Ulman Cancer Fund for Young Adults. The nonprofit organization is dedicated to supporting, educating and connecting young adults who are affected by cancer. Ulman is also known for his work at LIVESTRONG and now as president and CEO of Pelotonia.

All cancer survivors are invited, whether they were treated at Stony Brook or not. In addition to Ulman’s talk, attendees can enjoy a variety of outdoor activities, musical entertainment and light refreshments. They can also participate in the very moving Parade of Survivors. To register, visit www.cancer.stonybrookmedicine.edu/registration or call 631-444-4000.

Cancer Center staff members actively partake in the day’s events and look forward to reconnecting with patients. It’s gratifying for them to see the strides these survivors have made throughout the years to lead normal and productive lives after a cancer diagnosis.

National Cancer Survivors Day is just one of a number of ways Stony Brook reaches out to the community. The Cancer Center has created many initiatives and programs to help make life a little easier for patients with cancer, including support groups, cancer prevention screenings and the School Intervention and Re-Entry Program for pediatric patients.

As a leading provider of cancer services in Suffolk County, Stony Brook is constructing a state-of-the-art Medical and Research Translation (MART) building that will focus on cancer research and advanced imaging and serve as the home of our new Cancer Center. Located on the Stony Brook Medicine campus, this 245,000-square-foot facility will allow scientists and physicians to work side by side to research and discover new cancer treatments and technology.

The MART will double Stony Brook’s capacity for outpatient cancer services and enhance all cancer care for Long Island and beyond. And once it is completed in 2016, we’ll have one more reason to celebrate life after a cancer diagnosis.

L. Reuven Pasternak, MD, is the CEO of Stony Brook University Hospital and vice president for health systems, Stony Brook Medicine.

by -
0 2797
Doug Fearon. Photo from CSHL

Determined to help develop better treatments and, perhaps even a cure, Douglas Fearon, a medical doctor, decided to conduct research instead of turning to existing remedies. More than two decades later, Fearon joined Cold Spring Harbor Laboratory and is working on ways to help bodies afflicted with cancer heal themselves.

Fearon is focusing on the battle cancer wages with the T lymphocytes cells of human immune systems. Typically, these cells recognize threats to human health and destroy them. The pancreatic cancer cells he’s studying, however, have a protective mechanism that is almost like a shield. “The cancer is killing the T cells before the T cells can kill the cancer,” said Fearon.

The T cells have a complex signaling pathway on their surface that allows them to link up with other objects to determine whether these cells are friend or foe. In pancreatic cancer, Fearon has focused on a receptor that, when attached to the deadly disease, may disarm the T cell.

Researchers had already developed a small molecule that blocks the receptor on the T lymphocytes from linking up with this protein for another disease: the human immunodeficiency virus. When Fearon applied this molecule to a mouse model of pancreatic cancer, the therapy showed promise. “Within 24 hours, T cells were infiltrating the cancer cells,” he said. “Within 48 hours, the tumors had shrunk by 15 percent. This drug overcame the means by which cancer cells were escaping.”

This month, doctors at the University of Cambridge School of Clinical Medicine, where Fearon worked for 20 years, plan to begin Phase I human trials of this treatment for pancreatic cancer. Later this year, doctors at the Weill Cornell Medical College in New York City, where Fearon has a joint appointment, will begin a similar effort.

Scientists are encouraged by the early results from Fearon’s treatment. The Lustgarten Foundation named Fearon one of three inaugural “Distinguished Scholars” last year, awarding him $5 million for his research over the next five years.

The scientific advisory board at the Foundation “expects distinguished scholars to be on the leading edge of breakthrough therapies and understanding for this disease,” said David Tuveson, a professor and director of the Lustgarten Foundation Pancreatic Cancer Center Research Laboratory at CSHL.

During the early stage trials, doctors will increase the dosage to a level HIV patients had received during early experiments with the drug, called AMD 3100 or Plerixafor.

While Fearon is cautiously optimistic about this approach, he recognizes that there are many unknowns in developing this type of therapy. For starters, even if the treatment is effective, he doesn’t know whether the cancer may recur and, if it does, whether it might adapt some way to foil the immune system’s attempt to eradicate it.

Additionally, the receptor the doctors are blocking is required for many other functions in humans and mice. In mice, for example, the receptor on the T cell has a role in the developing nervous system and it also plays a part in a process called chemotaxis, which directs the migration of a cell.

“After giving this drug to HIV patients for 10 days, there were no long-term effects,” Fearon said. Researchers and doctors don’t “know for sure if you continued blocking this receptor what the long-term effects” would be.

Fearon and his wife Clare are renting a cottage in Lloyd Neck and have an apartment on the Upper East Side. Their daughter Elizabeth recently earned her Ph.D. in epidemiology in Cambridge, England while their son Tom, who is working toward a graduate degree in psychology, is interested in a career in counseling.

A native of Park Slope, Brooklyn who was the starting quarterback for Williams College in Massachusetts in his junior and senior years, Fearon feels it’s a “privilege to do something that may have a positive effect” on people’s lives.

Fearon is especially pleased to work at CSHL, where he said he can collaborate with colleagues who often immediately see the benefits of such a partnership. He has worked with Mikala Egeblad on intravital imaging, which is a type of microscope that allows him to look at living tissue. They are sharing the cost of buying a new instrument. Working with her “facilitated my ability to start up a project in my lab using a similar technique,” Fearon said.

Marissa Pastore and her mom, flanked by Disney characters. Photo from Katrina Kurczak

A 14-year-old Huntington Station girl who was recently diagnosed with a terminal illness got the wish of her life on Sunday when her favorite Disney characters came out to celebrate with her.

Marissa Pastore, who has been diagnosed with acute lymphoblastic leukemia (ALL) on April 20, was treated at the Cohen Children’s Center, but her fragile body was unable to handle the chemotherapy, according to a GoFundMe online fundraising account set up for the family. A few days later, Marissa returned home with her mom Risa, dad Domenick and two brothers Domenick and Ryan, to enjoy their final days together.

Marissa’s mom is an emergency department nurse at Huntington Hospital and her dad is a former Huntington Manor Fire Department chief and a fireman with the New York City Fire Department (FDNY), according to the account. Both are volunteers at the Huntington Manor Fire Department, and the account was set up so the family could “concentrate solely on loving Marissa.”

Marissa Pastore, 14, gets the surprise of a lifetime when Disney characters visit her. Photo from Katrina Kurczak
Marissa Pastore, 14, gets the surprise of a lifetime when Disney characters visit her. Photo from Katrina Kurczak

“Please help us support the Pastore family with any donation you can make which will go toward covering their living expenses while they take time off from work to celebrate Marissa’s life together.”

Not only did the account amass more than $55,000 by Wednesday, Marissa got a special surprise when Minnie Mouse, Mickey Mouse, Olaf and other characters from popular Disney movies greeted the 14-year-old Disney lover, thanks to the Make-A-Wish Foundation.

According to Katrina Kurczak, one of Marissa’s wish granters and assistant director of program services for Make-A-Wish, the nonprofit group and the family put together Marissa’s wish quickly. Family and community members contacted them Tuesday, April 28, and the group met with the family Wednesday. On Sunday, her wish came true.

“She was surprised and so happy, she couldn’t believe it,” Kurczak said. The characters rode in on fire trucks and greeted her.

The goal was to bring Disney to her, as Marissa is unable to travel due to her condition. Disney princesses Anna and Elsa from “Frozen” also made a special appearance and sang to the young girl.

“Her dad wanted to do something to make her smile,” Kurczak said.

Many volunteers came together to help make the day as special as possible. The Huntington Manor Fire Department, Cold Spring Harbor Fire Department and the FDNY also helped make Marissa’s wish come true.

To donate to the Pastore family, visit https://www.gofundme.com/sus6z8.

District Attorney Tom Spota holds up a jar Brittany Ozarowski used while falsely claiming she had cancer to solicit donations. File photo by Erika Karp

The Selden native who tricked Long Islanders into believing she had cancer and used donations to fund her heroin habit was sentenced to prison on Monday, after she violated the terms of a mandated drug treatment program, Suffolk County District Attorney Tom Spota said.

Brittany Ozarowski will spend one to three years behind bars after  violating the terms of her drug treatment program. File photo
Brittany Ozarowski will spend one to three years behind bars after violating the terms of her drug treatment program. File photo

In December 2013, Brittany Ozarowski, 24, pleaded guilty to two counts of third-degree larceny; 10 counts of second-degree forgery; 10 counts of first-degree offering a false instrument for filing; one count of first-degree scheming to defraud; and one count of petit larceny. While the District Attorney’s office wanted Ozarowski to serve a maximum seven-year prison term, Judge John Iliou instead required her to enroll in the Suffolk County Judicial Diversion Program, an alternative sentencing program that includes drug addiction treatment instead of jail. Ozarowski’s sentence included one year of inpatient treatment, one year of outpatient treatment and a year of probation.

On Monday, Spota announced in a press release that she had violated the program’s terms and had thus been sentenced to one to three years in prison.

George Duncan, a Central Islip-based attorney representing Ozarowski, said while Ozarowski received “technical violations” that resulted in her prison sentence, her time spent in the treatment program “literally saved her life,” and she is aware and thankful for that.

Duncan and the DA’s office were unable to specify how exactly Ozarowski broke program rules, as doing so would violate the federal health care privacy laws.

Ozarowski was indicted on 24 counts and arrested in April 2013. According to the DA’s office, she claimed she had bone and brain cancer to solicit donations from customers at supermarkets and shops throughout Long Island, including in Terryville, Miller Place and Sayville. In addition, she got local businesses to hold fundraisers to benefit her alleged treatments and created a website with a PayPal account where people could donate. In reality, she was using the money to fuel her heroin addiction.

At the time of her arrest, investigators discovered more than $317 in a donation bucket. More than 20 locations with donation jars were later found and the DA’s office estimated Ozarowski defrauded more than $6,000.

The 2013 arrest wasn’t Ozarowski’s first. She has other heroin-related charges against her, including a driving under the influence charge from 2011, which is still pending. The DA’s office said the Newfield High School graduate tampered with letters from doctors to say she had cancer and submitted them to her attorney in order to postpone court hearings on the charges.

‘Short But Sweet,’ the butterfly bra created by Tammy Colletti in memory of her mother. Photo by Erin Dueñas

By Erin Dueñas

Covered in feathers, decorated in shells and bedazzled in rhinestones, the bras on display at the Wang Center at Stony Brook University last Thursday looked like they could have been part of the latest collection from an eccentric lingerie designer. The bras were actually created by members of the community, local businesses, cancer survivors and television personalities as part of Bodacious Bras for a Cure, a fundraising event to benefit women’s cancer programs at Stony Brook Cancer Center.

Dr. Michael Pearl says the services offered to cancer patients involved in the cancer center help to restore some control in their lives. Photo by Erin Duenas
Dr. Michael Pearl says the services offered to cancer patients involved in the cancer center help to restore some control in their lives. Photo by Erin Duenas

Bodacious Bras was initiated by Linda Bily, director of Cancer Patient Advocacy and the Woman to Woman program at the center and inspired by a similar event called Creative Cups at Adelphi University. Bras were decorated and then put up for auction at the Stony Brook event. “It’s just a fun, different way of promoting awareness of all women’s cancers,” Bily said.

Twenty-two bras were auctioned off, raising $5,000 that will help fund women’s patient services at the Cancer Center.

According to Bily, each bra entry had to be created on a size 36C garment. Nothing perishable was permitted on the creations and the entire bra needed to be decorated. A brief summary accompanied each bra explaining the creator’s motivation. The “Mandala” bra, which fetched $250, created by local artist Jessica Randall, was made of shells and won the Best in Show prize. “I made this bra,” Randall’s summary read, “to honor women who have struggled with the debilitating disease of breast cancer.” “That Meatball Place” bra was created by the restaurant of the same name, located in Patchogue. Featuring bows and rhinestones and the restaurant’s logo, the bra fetched $500 at the auction. “Whichever [meatball] style suits you, we support them all, while always saving room for hope of a cure,” that summary read. Another bra called the “Hooter Holster” was created by Port Jefferson Station native Clinton Kelly, co-host of  “The Chew.”

22 bras were featured at Bodacious Bras for a Cure bringing in $5000 to fund women’s cancer services. Photo by Erin Duenas
22 bras were featured at Bodacious Bras for a Cure bringing in $5000 to fund women’s cancer services. Photo by Erin Duenas

Tammy Colletti of Setauket made a bra called “Short But Sweet” dedicated to her mother Marion who passed away a year and a half ago. Using purple and teal feathers, the bra was made to look like a butterfly. A small vial containing a piece of paper that read “Cure Breast Cancer” rested in the center in between the feathers.

Colletti, who volunteers at the Cancer Center, said she was inspired to create a butterfly bra after watching her mother live out the remainder of her life in hospice care. “When they brought her in to hospice she was all wrapped up, and I told her it looked like she was in a cocoon,” Colletti said. When she passed away, Colletti imagined her mother shedding that cocoon and turning into a butterfly. “She was transformed into something beautiful, into something that I know is flying all around us.”

The Cancer Center provides a wide variety of support to ill patients to help them cope with a cancer diagnosis. In the Woman to Woman program, patients can get help with childcare, transportation to treatments, financial assistance to pay for costs associated with being ill and selecting wigs if needed.

Dr. Michael Pearl, professor of medicine and chief of the Division of Gynecologic Oncology, said that a cancer diagnosis has a huge impact not just on the woman affected but on her family as well. “In a lot of families, the woman acts as the glue that keeps everything together,” Pearl said. When a woman gets sick, often the day-to-day operations of family life get disrupted. That is when the Woman to Woman program can step in.

“We have volunteers that provide active support services,” Pearl said. Services could even include driving a patient’s children to sports or band practice. “Getting sick takes away your control. The program tries to restore some control and normalcy into their day-to-day lives.”

Bily said she was expecting Bodacious Bras to take a while to catch on, but she was happy with the positive response of the event. “It was a great night,” she said. “People who designed a bra are already thinking about what they will make next year.”

by -
0 2276
Patricia Thompson photo from Stony Brook University

By Daniel Dunaief

Patricia Thompson gets a call from her sister Kathy Hobson when people in San Angelo, Texas — where Thompson grew up and where her sister and brother live — when someone has cancer. They want to know what Thompson thinks of their treatment.

While Thompson is not a medical doctor, she has been working as a scientist to develop ways to discriminate high-risk patient populations from low-risk patients to limit “toxic treatments in low-risk individuals” and improve the efficacy of aggressive treatment in high risk-patients. The goal, she said, is to better treat patients based on the specific pathobiology of their disease.

Thompson, who came to Stony Brook University last October as a professor of pathology and associate director of Basic Research at the Cancer Center, is pleased with the support from the university.

“There’s a real convergence of factors, including a strong commitment from the leadership, the Simons Center and the university medical school faculty and staff at Stony Brook,” she said. “We all want to see the Stony Brook Cancer Center bring prestige to our community, attract the finest talent in cancer research and clinical care and attract innovators and job builders.”

Thompson said Cancer Center Director Yusuf Hannun, Medical School Research Dean Lina Obeid, Pathology Department Chairman Ken Shroyer, and Dean of the Medical School Ken Kaushansky have all led the charge.
Shroyer is pleased Thompson joined the effort. “Bringing her here was an incredible coup,” he said. She brings “real national prominence” and led one of the “most important clinical and translational research programs in breast and colorectal cancer.”

Thompson is committed to furthering her own research studies, while balancing between critical basic science discoveries and their clinical impact.

For some scientists, she wants to assist researchers as they move from the bench to the first human study. She helps them understand who needs to be involved to advance a potential diagnostic tool or novel treatment.

Still, she endorses the benefits of basic research. “Application is always an important long-term goal, but scientific exploration for new discovery is critical to advancements,” she said. Applied and basic research are “neither mutually exclusive approaches.”

Thompson studies colorectal and breast cancer because both have an inflammatory component and an immune element. She’s exploring what is shared between these two cancers as common targets for prevention and treatment.

Colon cancer provides a window that helps scientists and doctors understand the way cancer progresses.
“Our ability to study the premalignant to malignant progression in colorectal cancer has provided important basic knowledge of how cancers develop and taught us about how cells defend against tumorigenesis and how these systems fail,” she said.

Thompson went through some formative professional and personal experiences during graduate school that shaped her career. In the mid-1990s, she was studying an autoimmune disease in which she worked on an animal model with a neuroimmunologist.

“I wanted to know that all this work I was doing with animals was contributing to the disease in humans,” she said.

Around the same time, her father, Jim Thompson, who owned and operated Angelo Tool Company, learned he had stage IV colorectal cancer. He was diagnosed in 1995, before major advances in colorectal cancer treatment. Her father received compassionate care use of a new therapy, enabling him to live for three more years, considerably longer than his initial two-month prognosis. If he had been diagnosed five years later and received a platinum-based regimen, he would have “gained even more time,” she said.

Thompson said she and her family struggle with the fact that her father showed symptoms he kept to himself, largely out of fear. If his cancer had been detected earlier, she believes it is likely he could have been cured.

She suggests people not be “afraid of a cancer diagnosis” and recommends “routine screening” and consultation with a doctor if they show symptoms.

Thompson lives in Rocky Point with her husband, Michael Hogan, who is the vice president of life sciences at Applied DNA Sciences.

As for her work, Thompson believes her research might help physicians and their patients.
Her research aims to develop “diagnostic tests that help in prognosis” while identifying “patients that may achieve more benefit from aggressive chemotherapy,” she said.

A view of Cold Spring Harbor Laboratory. File photo

Cold Spring Harbor Laboratory and the North Shore-LIJ Health System say they are partnering up to align research with clinical services in an effort to treat the health system’s nearly 16,000 cancer cases each year.

The partnership, announced last week, will benefit from more than $120 million investment that will be used to accelerate cancer research, diagnosis and treatment. The money will also be used to develop a new clinical research unit at the North Shore-LIJ Cancer Institute in Lake Success, NY. The unit will support the early clinical research of cancer therapies while also being used to train clinicians in oncology, the branch of medicine that deals with cancer. The source of the investment is not being disclosed.

“This is a transformative affiliation for both institutions, bringing the cutting-edge basic discovery science and translational cancer research at CSHL to one of the largest cancer treatment centers in the United States,” Cold Spring Harbor Lab President and CEO Bruce Stillman said in a press release.

As part of the affiliation, clinician-scientists will also be trained to perform preclinical cancer research and conduct early-stage human clinical trials to help further research.

“Cancer patients at North Shore-LIJ are going to benefit from the world’s leading cancer research centers,” Dagnia Zeidlickis, vice president of communications for Cold Spring Harbor Lab said in a phone interview Monday.

The partnership is just the latest move made by North Shore-LIJ to improve cancer care. Over the past two years, the health system invested more than $175 million to expand cancer treatment centers throughout Long Island and New York City.

Recently, North Shore-LIJ completed an $84 million expansion of the institute’s headquarters in Lake Success. It consolidated all cancer services offered by North Shore University Hospital and Long Island Jewish Medical Center in a state-of-the-art 130,000-square-foot facility, including ambulatory hematology/oncology, chemotherapy and radiation medicine, surgical oncology and brain tumor services, according to a press release.

North Shore-LIJ is also building a new $34 million, 45,500-square-foot outpatient cancer center in Bay Shore and is pursuing other major expansions on Long Island and in Manhattan, Queens, Staten Island and Westchester County.

“Bringing the scientists of Cold Spring Harbor Laboratory together with the more than 200 academic oncologists and clinicians of the North Shore-LIJ Cancer Institute will transform our approach to cancer research and treatment throughout the New York area,” North Shore-LIJ President and CEO Michael Dowling said in a statement.

Cold Spring Harbor Lab’s researchers have been studying cancer since the early 70s and have made several discoveries that have helped diagnose and treat cancer patients. In 1982, the lab was part of the discovery of the first human cancer gene. The Cold Spring Harbor Laboratory Cancer Center has been a National Cancer Institute-designated cancer center since 1987, and is the only such center on Long Island, according to the statement.

The lab’s research focuses on many different types of cancers: breast, lung, prostate, pancreas, cervix, ovary and skin, as well as leukemia and lymphoma, carcinoid tumors, sarcomas and more.

The cancer institute is part of the 19 health systems that makes up the North Shore-LIJ Health System. According to Zeidlickis, North Shore-LIJ cares for more than 16,000 new cancer cases each year and is New York State’s largest hospital system.

Under the terms of the partnership, both North Shore-LIJ and Cold Spring Harbor Laboratory will continue as independent organizations governed by their respective boards of trustees.

by -
0 2339
John Haley photo from SBU

By Daniel Dunaief

Once they reach their destination, they wreak havoc, destroying areas critical to life. All too often, when cancer spreads, or metastasizes, through the body, it becomes fatal.

John Haley, a Research Associate Professor in the Pathology Department at Stony Brook, is trying to figure out how cancer become metastatic and, even further, what they do to avoid recognition by the immune system.

Haley is “working on the mechanisms by which metastasis occurs,” he said. He is also studying the “immune recognition of tumor cells and, in the near future, wants to link the two.”

Understanding the way metastasis works can greatly reduce mortality in cancer, Haley said. Researchers are currently attempting to develop therapies that target metastatic cells, but these are often more difficult to kill than their primary counterparts, Haley explained.

The stakes are high, as 90 percent of cancer deaths are due to complications from the spread of cancer rather than the primary tumor itself, he said.

About 80 percent of human cancers are carcinomas, which are derived from epithelial cells. Those are the cells that make up the skin, and line the stomach and intestines.

“As cancers become metastatic, those cells have the ability to shape shift,” he said.

They become much more like fibroblasts, which are underneath the skin and glue the skin to bone and make up connective tissue layers. Haley said he has made some progress in understanding the molecular mechanism that allows cells to shift from epithelial to fibroblastic cells. They have “defined factors which promote” this transition, with differences in survival and growth pathways.

Haley works with a machine called a mass spectrometer, in which he identifies proteins in complex biological samples and measures how changes in composition alters function. He spends about half his time working on his own research and the other half assisting other researchers who are seeking to get a clearer view of key changes in proteins in their work.

In his own research, he wants to understand how cancers modify a cell’s proteins. He has helped define how cancers can change their protein signaling pathways to become drug resistant, which suggests targets for drug therapies.

Haley is tapping into an area of science that many other researchers are exploring, called bioinformatics. Using statistics and mathematical models, these scientists are cutting down on the number of genes and proteins they study, honing in on the ones that have the greatest chance to cause, or prevent, changes in a cell.

“We’re taking the data sets we’ve generated and trying to predict what we should look for in human patient samples,” Haley said. “We can find a tumor cell that have mutations or this expression profile and find drugs they are sensitive to.” Once scientists find those drugs, researchers can test them in cell cultures, then in mouse models and eventually in people, he said.

“We try to isolate someone’s cancer to understand what the molecular drivers are that occur in that cancer,” Haley said. The approach, as it is much of modern medicine, is to understand the patient’s genetics and biochemistry to select for a drug that would be effective against the particular mutations present in their tumor.

A resident of Sea Cliff, Haley is married to Lesley, whom he met while he was pursuing his PhD at Melbourne University. A native Australian, Lesley was completing her Masters in Opera when the couple met at a tennis match. They still play today. Lesley has sung at New York premieres for several living composers at concert venues including Avery Fischer Hall. She teaches music at her studio in Sea Cliff. Their children share their interests. John is a freshman studying biochemistry at Stony Brook University and Emma, who is a senior at North Shore High School, plans to study science and singing.

As for his work, Haley would like to see his efforts culminate in cancer therapies and diagnostics. Any novel therapy might also become a product for a start up company which could create jobs on Long Island. “There are some fabulous scientists” at the university, he said. “A major goal of the Center for Biotechnology and Diane Fabel, its director, is to create small businesses here in New York. I’m trying to help them in that goal.”

by -
0 2520
Scott Powers with his wife Diane at a recent Cancer Research Gala. Photo by Julie Skarratt

By Daniel Dunaief

He spent 20 years looking at the problem in one way. Now, he’s ready for a change and Stony Brook officials stand behind him. After working in genomics at several locations, including for a decade as director of human cancer genomics at Cold Spring Harbor Laboratory to find therapeutic targets for human tumors, Scott Powers recently embraced the opportunity to find better ways to diagnose different types of cancer.

“A major driver for me coming to Stony Brook was to work on earlier detection,” Powers said.

Working with pathology department Chairman Ken Shroyer and Stony Brook obstetrician/gynecologist Michael Pearl, Powers is hoping to develop a prototype test for early detection of ovarian cancer so it can be removed by “simple surgery,” he said.

Powers has worked in numerous ways to isolate or identify mutations that might lead to cancer. That work focused on finding drug targets or developing therapies. One of the many challenges in studying genomics is that some mutations are bystanders, which means they likely don’t have a role in causing cancer or even, necessarily, in enabling cancer to spread. They make it harder to know whether they have a role or are merely different from the range of normal in a genetic sequence.

Some of the ways Powers has understood the potential part mutations play is by taking a computational approach, which can take many forms, including finding gene networks that are frequently altered. This approach has helped find various targets for therapies and improve the classification of tumors.

Powers said the “poster child” for success of this method was the development of the Oncotype DX test for breast cancer, which allows patients with node-negative, ER-positive breast cancer to determine whether they need to take chemotherapy.

He has also compared the gene sequences for similar cancer types across different species. He and Scott Lowe, who is now at Memorial Sloan Kettering Cancer Center, found this approach could “help identify drivers and, in a sense, help filter out passengers,” he said. This has been successful on a basic science level but hasn’t yet led to the identification of a viable new therapeutic strategy, he said.

Powers’ focus now is to direct his expertise toward developing a test that might address early detection and, in some cases, improved diagnosis.

“It’s a brand new set of things for me to think about,” Powers said. The effort, he believes, should prove reinvigorating. The intellectual challenge of coming up with a solution that improves or enhances someone’s life motivates him.

Powers supports Stony Brook’s effort to add staff and develop a pool of researchers who can develop techniques and tools to aid in the diagnosis and treatment of cancer. “I am very hopeful for Stony Brook to build up an intellectually interesting environment that will attract a new generation of cancer scientists to come on board,” he said.

Powers believes cancer is a complex disease that has many different variations. “Many random events occur that sometimes give the cancer cell a competitive survival advantage,” he explained. “Everyone’s tumor has its own unique combination of 10 to 25 genetic alterations that are driving it.”

In addition to working with Shroyer on developing diagnostic tools for the genomics of cancer, Powers has turned his attention toward other researchers on the campus with different backgrounds. He is planning a collaboration with Sasha Levy, who works at the Laufer Center for Physical and Quantitative Biology and is an assistant professor of biochemistry and cell biology, to study cancer evolution. He said they’ll be using experimental methods Levy has developed on yeast.

Yusuf Hannun, the director of the Cancer Center, has recruited Powers to participate on the tumor board, which is where physicians from different areas come to discuss specific patients in a multidisciplinary fashion.

“There are numerous discussions and plans to expand upon this growing trend to use genetic testing in developing a personalized strategy for each patient,” Powers said.

Powers and his wife Diane, who works in fundraising with Patricia Wright at Stony Brook in the anthropology department, live in Greenlawn with their daughter Camille, who is a sophomore at Harborfields High School. Their other children are Alexander, 25, who works for a nonprofit in Brooklyn called the Social Science Research Council, and Douglas, 21, who is a junior studying applied math at Harvard.

Powers was looking for two things that he found when he came to Stony Brook: “the chance to develop diagnostic tests” and to “enter new fields by finding new collaborators with scientists doing interesting things.”